Inspira Technologies Oxy BHN (IINN) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Inspira Technologies has partnered with Westchester Medical Center to evaluate its FDA-cleared INSPIRA ART100 system in clinical settings, highlighting a potential breakthrough in treating acute respiratory failure. This collaboration aims to enhance patient care with advanced technology, potentially paving the way for future innovations in respiratory treatment. Investors may find interest in this development as it underscores the growing recognition and application of Inspira’s innovative medical technologies.
For further insights into IINN stock, check out TipRanks’ Stock Analysis page.